Correlation Between Third Harmonic and Inhibikase Therapeutics
Can any of the company-specific risk be diversified away by investing in both Third Harmonic and Inhibikase Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Third Harmonic and Inhibikase Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Third Harmonic Bio and Inhibikase Therapeutics, you can compare the effects of market volatilities on Third Harmonic and Inhibikase Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Third Harmonic with a short position of Inhibikase Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Third Harmonic and Inhibikase Therapeutics.
Diversification Opportunities for Third Harmonic and Inhibikase Therapeutics
0.33 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Third and Inhibikase is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding Third Harmonic Bio and Inhibikase Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inhibikase Therapeutics and Third Harmonic is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Third Harmonic Bio are associated (or correlated) with Inhibikase Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inhibikase Therapeutics has no effect on the direction of Third Harmonic i.e., Third Harmonic and Inhibikase Therapeutics go up and down completely randomly.
Pair Corralation between Third Harmonic and Inhibikase Therapeutics
Given the investment horizon of 90 days Third Harmonic is expected to generate 11.12 times less return on investment than Inhibikase Therapeutics. But when comparing it to its historical volatility, Third Harmonic Bio is 1.49 times less risky than Inhibikase Therapeutics. It trades about 0.01 of its potential returns per unit of risk. Inhibikase Therapeutics is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 182.00 in Inhibikase Therapeutics on September 2, 2024 and sell it today you would earn a total of 110.00 from holding Inhibikase Therapeutics or generate 60.44% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Third Harmonic Bio vs. Inhibikase Therapeutics
Performance |
| Timeline |
| Third Harmonic Bio |
| Inhibikase Therapeutics |
Third Harmonic and Inhibikase Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Third Harmonic and Inhibikase Therapeutics
The main advantage of trading using opposite Third Harmonic and Inhibikase Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Third Harmonic position performs unexpectedly, Inhibikase Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inhibikase Therapeutics will offset losses from the drop in Inhibikase Therapeutics' long position.| Third Harmonic vs. Sensei Biotherapeutics | Third Harmonic vs. NextCure | Third Harmonic vs. Nuvation Bio | Third Harmonic vs. Cullinan Oncology LLC |
| Inhibikase Therapeutics vs. DiaMedica Therapeutics | Inhibikase Therapeutics vs. Milestone Pharmaceuticals | Inhibikase Therapeutics vs. Seres Therapeutics | Inhibikase Therapeutics vs. Oncolytics Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Complementary Tools
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |